Tag Archives: Dexedrine

Pharmacotherapy of Adult ADHD

Originally conceptualized as a disorder of childhood (), attention deficit hyperactivity disorder (ADHD) is increasingly recognized in adults. attention deficit hyperactivity disorder is estimated to affect 2-9% of school-age children and up to 5% of adults (). Although some investigators question the persistence of attention deficit hyperactivity disorder in adulthood (), long-term controlled follow-up studies… Read More »

What medications are used to treat ADHD in women and girls?

Research and clinical experience have shown that stimulant medications are the most effective first-line treatment for ADHD in both males and females. Currently, there are many medication formulations, including stimulants (methylphenidate and amphetamine preparations) and nonstimulants for the treatment of attention-deficit/hyperactivity disorder. Although a few skeptics continue to voice concerns over the prescription of medication… Read More »

Information about ADHD for Patients and Families

Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in young and school-aged children. However, it is not merely a childhood disorder. In recent years, an increasing number of adults have been diagnosed with ADHD, raising some concern that it may be overdiagnosed. Estimates of the prevalence (i.e., percentage of the population affected) of attention-deficit/hyperactivity disorder… Read More »

The pharmaceutical industry and the new drugs

The pharmaceutical industry played a significant part in establishing the role of the new psychiatric drugs in the 1950s and 1960s. For doing so it is sometimes credited with helping transform psychiatry into a modern ‘medical specialism’. The large-scale marketing campaigns that helped to establish the use of the early neuroleptic and antidepressant drugs are… Read More »

Tardive Dyskinesia

Uncommon, Predictable, Potentially Serious Correll, Leutch, and Kane (2004) conducted a meta-analytic review of 11 long-term studies of second generation antipsychotics; their study supports the expectation that atypical antipsychotics have a reduced risk for tardive dyskinesia compared to first generation antipsychotics. This finding was true for children, adults, and particularly, for the vulnerable population of… Read More »